Noguchi S, Murakami N, Kawamoto H
Noguchi Thyroid Clinic and Hospital Foundation, Oita-ken, Japan.
World J Surg. 1994 Jul-Aug;18(4):552-7; discussion 558. doi: 10.1007/BF00353763.
Between 1965 and 1988 there were 2953 patients with papillary carcinoma treated at Noguchi Thyroid Clinic. Among them 761 patients were excluded because the primary tumor was < 10 mm in maximum diameter, the patient's age was > 80, or the patient underwent noncurative surgery. The remaining 2192 patients, 192 men and 2000 women, were analyzed. The mean follow-up period was 12.5 years. Total thyroidectomy, subtotal thyroidectomy, lobectomy with or without isthmectomy, and less than lobectomy were performed in 2.3%, 40.3%, 44.2%, and 13.2%, respectively. Modified radical neck dissection, partial node excision, and no node excision were performed in 77.8%, 6.4%, and 15.8%, respectively. Men and women were separately analyzed because their risk factors and prognosis were significantly different. Multivariate analysis was carried out according to Cox's regression hazard model. Independently significant factors affecting prognosis in men were aged and gross nodal metastasis; and age, gross nodal metastasis, tumor size, and number of adhered tissues or organs were the factors in women. Based on those risk factors patients were classified into three groups. For men, 65.6% were classified in the excellent group and their 10-year survival was 98.4%; 17.2% were classified as intermediate and 17.2% as poor with survival rates of 90.1% and 74.4%, respectively. For female patients 69.6% were classified in the excellent group, 18.6% in the intermediate group, and 11.9% in the poor group with 10-year survivals of 99.3%, 96.4%, and 88.8%, respectively.
1965年至1988年间,野口甲状腺诊所共治疗了2953例乳头状癌患者。其中761例患者被排除,原因是原发肿瘤最大直径<10mm、患者年龄>80岁或患者接受了非根治性手术。对其余2192例患者(192例男性和2000例女性)进行了分析。平均随访期为12.5年。全甲状腺切除术、次全甲状腺切除术、有或无峡部切除术的叶切除术以及小于叶切除术的实施率分别为2.3%、40.3%、44.2%和13.2%。改良根治性颈清扫术、部分淋巴结切除术和未行淋巴结切除术的实施率分别为77.8%、6.4%和15.8%。由于男性和女性的危险因素及预后存在显著差异,因此对他们分别进行了分析。根据Cox回归风险模型进行多变量分析。影响男性预后的独立显著因素是年龄和大体淋巴结转移;而年龄、大体淋巴结转移、肿瘤大小以及粘连组织或器官的数量是影响女性预后的因素。基于这些危险因素,将患者分为三组。对于男性,65.6%被归类为优秀组,其10年生存率为98.4%;17.2%被归类为中等组,17.2%被归类为差组,生存率分别为90.1%和74.4%。对于女性患者,69.6%被归类为优秀组,18.6%被归类为中等组,11.9%被归类为差组,其10年生存率分别为99.3%、96.4%和88.8%。